Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,320,469
in 18 filings, $12.5M under 10b5-1 plans

Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-07 Malik Fady Ibraham EVP Research & Development Exercise or conversion · Incentive Stock Option (Right to Buy) 10b5-1 −14,186 0
2024-04-25 HENDERSON JOHN T Director Sale 10b5-1 −10,562 $64.54 $682K 32,070
2024-04-12 Malik Fady Ibraham EVP Research & Development Gift −150 138,417
2024-04-09 Malik Fady Ibraham EVP Research & Development Exercise or conversion 10b5-1 +28,605 $6.67 $191K 171,172
2024-04-09 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −28,605 $74.31 $2.1M 142,567
2024-04-09 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −4,000 $74.32 $297K 138,567
2024-04-09 Malik Fady Ibraham EVP Research & Development Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −28,605 0
2024-03-14 Wong Robert VP, Chief Accounting Officer Grant or award +4,079 29,664
2024-03-14 Wong Robert VP, Chief Accounting Officer Grant or award · Incentive Stock Option (Right to Buy) +1,403 1,403
2024-03-14 Wong Robert VP, Chief Accounting Officer Grant or award · Non-Qualified Stock Option (Right to Buy) +3,308 3,308
2024-03-14 Callos Andrew EVP, Chief Commercial Officer Grant or award +16,941 63,887
2024-03-14 Callos Andrew EVP, Chief Commercial Officer Grant or award · Non-Qualified Stock Option (Right to Buy) +18,346 18,346
2024-03-14 Callos Andrew EVP, Chief Commercial Officer Grant or award · Incentive Stock Option (Right to Buy) +1,224 1,224
2024-03-14 Malik Fady Ibraham EVP Research & Development Grant or award +21,333 142,567
2024-03-14 Malik Fady Ibraham EVP Research & Development Grant or award · Incentive Stock Option (Right to Buy) +1,541 1,541
2024-03-14 Malik Fady Ibraham EVP Research & Development Grant or award · Non-Qualified Stock Option (Right to Buy) +23,103 23,103
2024-03-14 Blum Robert I President & CEO Grant or award +61,490 461,221
2024-03-14 Blum Robert I President & CEO Grant or award · Incentive Stock Option (Right to Buy) +1,568 1,568
2024-03-14 Blum Robert I President & CEO Grant or award · Non-Qualified Stock Option (Right to Buy) +69,464 69,464
2024-03-06 Wong Robert VP, Chief Accounting Officer Shares withheld for taxes −857 $66.88 $57K 25,585

Page 34 of 45 · 885 trades